Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Andrew Kent

Concepts (41)

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with Andrew Kent's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Andrew Kent has written about over time.
Neoplasm Recurrence, Local, 1 publications between 2020 and 2020, average publication date July 2020. CD3 Complex, 1 publications between 2021 and 2021, average publication date May 2021. Genetic Engineering, 1 publications between 2021 and 2021, average publication date May 2021. Genetic Variation, 1 publications between 2021 and 2021, average publication date May 2021. Neoplasms, 1 publications between 2021 and 2021, average publication date May 2021. Receptors, Antigen, T-Cell, 1 publications between 2021 and 2021, average publication date May 2021. Signal Transduction, 1 publications between 2021 and 2021, average publication date May 2021. Stem Cell Transplantation, 2 publications between 2020 and 2023, average publication date December 2021. Immunotherapy, Adoptive, 2 publications between 2021 and 2022, average publication date February 2022. T-Lymphocytes, 3 publications between 2021 and 2023, average publication date August 2022. Leukemia, Myeloid, Acute, 6 publications between 2020 and 2023, average publication date October 2022. Sulfonamides, 2 publications between 2022 and 2023, average publication date December 2022. Leukemia, Lymphocytic, Chronic, B-Cell, 1 publications between 2022 and 2022, average publication date December 2022. Precursor Cell Lymphoblastic Leukemia-Lymphoma, 1 publications between 2022 and 2022, average publication date December 2022. Bridged Bicyclo Compounds, Heterocyclic, 3 publications between 2022 and 2023, average publication date March 2023. Hematologic Neoplasms, 2 publications between 2022 and 2023, average publication date April 2023. Hematopoietic Stem Cell Transplantation, 1 publications between 2023 and 2023, average publication date April 2023. Cell- and Tissue-Based Therapy, 1 publications between 2023 and 2023, average publication date August 2023. Gamma Rays, 1 publications between 2023 and 2023, average publication date August 2023. Azacitidine, 1 publications between 2023 and 2023, average publication date September 2023.

To see the data from this visualization as text, click here.
Kent's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)